| Net Income | 10.5M |
| Depreciation and amortization | 9.63M |
| Bad debt expense | -82K |
| Amortization of discount and other non-cash interest expense | 476K |
| Deferred income taxes, net | 2.82M |
| Non-cash charges for equity instruments issued for compensation and services | 2.09M |
| Accounts receivable | 2.2M |
| Prepaid expenses and other assets | 1.63M |
| Accounts payable | -8K |
| Accrued expenses | -2.99M |
| Other liabilities | -2.94M |
| Net cash provided by operating activities | 23.34M |
| Purchases of property and equipment | -2.4M |
| Acquisition, net of cash acquired | 0 |
| Net cash used in investing activities | -2.4M |
| Proceeds from sale of stock and exercise of options | 1.31M |
| Borrowings of notes payable | 5.35M |
| Repayments of notes payable and capital lease | -34.42M |
| Dividends paid | 0 |
| Net cash (used in) provided by financing activities | -27.76M |
| Effect of foreign exchange rate changes on cash and cash equivalents | -828K |
| Net decrease in cash and cash equivalents | -7.64M |
| Cash and Cash Equivalents, beginning of period | 30.18M |
| Cash and Cash Equivalents, end of period | 22.54M |